Creative Medical Technology Holdings (CELZ) EPS (Basic) (2010 - 2026)
Creative Medical Technology Holdings (CELZ) posted quarterly EPS (Basic) of -$0.23 for Q1 2026, up 41.74% year-over-year from -$0.16 in Q1 2025, and up 37.05% quarter-over-quarter from -$0.37 in Q4 2025.
Creative Medical Technology Holdings (CELZ) EPS (Basic) (2010 - 2026) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported EPS (Basic) for 17 consecutive years, with -$0.23 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 41.74% year-over-year to -$0.23; the TTM figure through Mar 2026 stood at -$1.0 (up 42.48% YoY), while the FY2025 annual figure was -$1.04, up 50.0% from the prior year.
- EPS (Basic) improved to -$0.23 in Q1 2026 per CELZ's latest filing, from -$0.37 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.23 in Q1 2026 and bottomed at -$5.69 in Q4 2022.
- Historically, EPS (Basic) has averaged -$1.12 across 5 years, with a median of -$0.75 in 2023.
- On a YoY basis, EPS (Basic) climbed as much as 90.71% in 2022 and fell as far as 101.6% in 2022.
- Creative Medical Technology Holdings' EPS (Basic) stood at -$5.69 in 2022, then jumped by 79.03% to -$1.19 in 2023, then grew by 21.62% to -$0.93 in 2024, then surged by 60.89% to -$0.37 in 2025, then surged by 37.05% to -$0.23 in 2026.
- Business Quant data shows CELZ's EPS (Basic) at -$0.23 in Q1 2026, -$0.37 in Q4 2025, and -$0.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - | -1.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.17 |
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | -0.37 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.39 |
| Dec 31, 2024 | -0.93 |
| Sep 30, 2024 | -0.75 |
| Jun 30, 2024 | -1.11 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | -1.19 |
| Sep 30, 2023 | -1.02 |
| Jun 30, 2023 | -0.78 |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -5.69 |
| Sep 30, 2022 | -0.70 |
| Jun 30, 2022 | -1.99 |
| Mar 31, 2022 | -1.79 |
| Dec 31, 2021 | -11.93 |
| Sep 30, 2021 | -7.52 |